Ultima Genomics is a developer of a low-cost sequencing platform.
Ultima Genomics has raised $600.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
Ultima Genomics's investors include Andreessen Horowitz, General Atlantic, Lightspeed Venture Partners, Founders Fund, Khosla Ventures.
Ultima Genomics is headquartered in Newark, United States.
Ultima Genomics is a developer of a low-cost sequencing platform.
Ultima Genomics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ultima Genomics — Funding & Investors." VCBacked, May 31, 2022, https://www.vcbacked.co/company/ultima-genomics. Accessed August 14, 2026.
VCBacked. (2022). Ultima Genomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ultima-genomics
{{cite web |title=Ultima Genomics — Funding & Investors |url=https://www.vcbacked.co/company/ultima-genomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated